Gan & Lee Pharmaceuticals Begins First-In-Human Trial in U.S. for Investigational Drug, GZR18
BEIJING and BRIDGEWATER, N.J., March 10, 2022 /PRNewswire/ — Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan
Read MoreBEIJING and BRIDGEWATER, N.J., March 10, 2022 /PRNewswire/ — Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan
Read MoreBEIJING and PHILADELPHIA, Jan. 24, 2022 /PRNewswire/ — Applied Pharmaceutical Science, Inc. (“APS” or “the Company”), has recently announced the
Read MoreBEIJING and BRIDGEWATER, N.J., Dec. 6, 2021 /PRNewswire/ — Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan &
Read More